Semi-specific immuno-absorption and monoclonal antibody therapy in ANCA positive vasculitis: experience in four cases.

Semi-specific immuno-absorption and monoclonal antibody therapy in ANCA positive vasculitis: experience in four cases.

The treatment of renal limited systemic vasculitis usually involves a combination of cytotoxic drugs and steroids. As shown by randomised prospective controlled trial, plasmapheresis may be of additional benefit for the management of patients with renal involvement severe enough to require dialysis...

Полное описание

Библиографические подробности
Главные авторы:	Elliott, J, Lockwood, C, Hale, G, Waldmann, H
Формат:	Journal article
Язык:	English
Опубликовано:	1998

Схожие документы

Monoclonal-antibody therapy in systemic vasculitis.
по: Mathieson, P, и др.
Опубликовано: (1990)

MONOCLONAL-ANTIBODY THERAPY IN SYSTEMIC VASCULITIS
по: Mathieson, P, и др.
Опубликовано: (1990)

HUMANIZED MONOCLONAL-ANTIBODY THERAPY FOR SYSTEMIC VASCULITIS
по: Lockwood, C, и др.
Опубликовано: (1993)

Long-term remission of intractable systemic vasculitis with monoclonal antibody therapy.
по: Lockwood, C, и др.
Опубликовано: (1993)

MONOCLONAL-ANTIBODIES IN SYSTEMIC VASCULITIS - LONG-TERM BENEFIT FROM SHORT-TERM THERAPY
по: Isaacs, J, и др.
Опубликовано: (1993)

Personalized Medicine in ANCA-Associated Vasculitis ANCA Specificity as the Guide?
по: Zachary S. Wallace, и др.
Опубликовано: (2019-12-01)

Specificity of monoclonal antibody Campath-1.
по: Hale, G, и др.
Опубликовано: (1988)

ANCA POSITIVE AND ANCA NEGATIVE MICROSCOPIC POLYARTERITIS
по: Adu, D, и др.
Опубликовано: (1994)

HUMANIZED MONOCLONAL-ANTIBODY (MAB) THERAPY FOR WEGENERS GRANULOMATOSIS (WG)
по: Lockwood, C, и др.
Опубликовано: (1995)

Treatment of refractory Wegener's granulomatosis with humanized monoclonal antibodies.
по: Lockwood, C, и др.
Опубликовано: (1996)

Relapse Predictors in Antineutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis
по: Katarzyna Wawrzycka-Adamczyk, и др.
Опубликовано: (2024-08-01)

Relapse in Anti-Neutrophil Cytoplasm Antibody (ANCA)–Associated Vasculitis
по: Alan D. Salama
Опубликовано: (2020-01-01)

Importance of antigen specificity for complement-mediated lysis by monoclonal antibodies.
по: Bindon, C, и др.
Опубликовано: (1988)

Updates in ANCA-associated vasculitis
по: Carolyn Ross, и др.
Опубликовано: (2022-07-01)

Epidemiology of ANCA associated vasculitis
по: Wenche Koldingsnes, и др.
Опубликовано: (2008-01-01)

Positive predictive value of anti-neutrophil cytoplasmic antibody (ANCA) testing for ANCA-associated systemic vasculitis (AASV) in a routine clinical setting
по: McLaren, J, и др.
Опубликовано: (2001)

The Diagnosing Challenge of a Positive ANCA Vasculitis in the Paediatric Age
по: Clara Preto, и др.
Опубликовано: (2017-01-01)

Simultaneous automated screening and confirmatory testing for vasculitis-specific ANCA.
по: Mandy Sowa, и др.
Опубликовано: (2014-01-01)

Pathogenesis and pathology of anti-neutrophil cytoplasmic antibody（ANCA）-associated vasculitis
по: Daisuke Tsukui, и др.
Опубликовано: (2021-01-01)

Placebo-controlled trial of intravenous immunoglobulin in ANCA-associated systemic vasculitis.
по: Jayne, D, и др.
Опубликовано: (1999)

Intravenous immunoglobulin for ANCA-associated systemic vasculitis with persistent disease activity.
по: Jayne, DR, и др.
Опубликовано: (2000)

Therapeutic potential of rat monoclonal antibodies: isotype specificity of antibody-dependent cell-mediated cytotoxicity with human lymphocytes.
по: Hale, G, и др.
Опубликовано: (1985)

Explaining fatigue in ANCA-associated vasculitis.
по: Basu, N, и др.
Опубликовано: (2013)

Damage assessment in ANCA-associated vasculitis.
по: Bhamra, K, и др.
Опубликовано: (2012)

Explaining fatigue in ANCA-associated vasculitis
по: Basu, N, и др.
Опубликовано: (2013)

Diagnosis and management of ANCA associated vasculitis.
по: Berden, A, и др.
Опубликовано: (2012)

Cutaneous manifestations of ANCA-associated vasculitis
по: Chiesafuxench, Z, и др.
Опубликовано: (2016)

Cardiovascular outcomes in ANCA associated vasculitis
по: Mukhtyar, C, и др.
Опубликовано: (2008)

Outcome measures in ANCA-associated vasculitis.
по: Suppiah, R, и др.
Опубликовано: (2010)

The involvement of NETs in ANCA-associated vasculitis
по: Satoka Shiratori-Aso, и др.
Опубликовано: (2023-09-01)

Vasculitis ANCA y esclerosis sistémica
по: Maite Hurtado, и др.
Опубликовано: (2016-11-01)

Complement Inhibition in ANCA-Associated Vasculitis
по: Vladimir Tesar, и др.
Опубликовано: (2022-07-01)

Individualization of the ANCA associated vasculitis treatment
по: Zbigniew Zdrojewski
Опубликовано: (2014-09-01)

Update of Management of ANCA-Associated Vasculitis
по: Hoi San Tang, и др.
Опубликовано: (2021-12-01)

Advantages of rat monoclonal antibodies.
по: Clark, M, и др.
Опубликовано: (1983)

Correction: Simultaneous Automated Screening and Confirmatory Testing for Vasculitis-Specific ANCA.
по: Mandy Sowa, и др.
Опубликовано: (2015-01-01)

Correction: simultaneous automated screening and confirmatory testing for vasculitis-specific ANCA.
по: PLOS ONE Staff
Опубликовано: (2015-01-01)

Anti-plasminogen antibodies in ANCA-associated vasculitis: An optimized anti-plasminogen assay.
по: Arda Göçeroğlu, и др.
Опубликовано: (2018-01-01)

CAMPATH-1 monoclonal antibodies in bone marrow transplantation.
по: Hale, G, и др.
Опубликовано: (1994)

Interest of a Kidney Biopsy to Rule out ANCA-Associated Renal Vasculitis in Glomerulonephritis Patients with a Positive ANCA
по: Florian Garo, и др.
Опубликовано: (2022-04-01)